FirmAtlas
Company handbook · P · Prepared by FirmAtlas · firmatlas.app · printed 2026-10-16
P · CIK 1474432 · LATEST FILING: 10-Q AUG '26 · FILED SEP 4, 2026
Everpure, Inc.
$124.01
−9.39 (−7.04%)
Close, Oct 16, 2026 · 52-week $57–158
Last fiscal year
Everpure, Inc. reported revenue of $3.7B for the year ended Feb 1, 2026 (FY25), up 15.6% from FY24. Net income was $188M, operating cash flow $880M and free cash flow $616M. Source: 10-K filed Mar 25, 2026.
Market cap
$42.5B
P/E
167.9
EV/EBITDA
165.6x
P/B
27.6
ROIC
15.4%
Revenue 1Y
15.6%/yr
EPS 1Y
77.4%/yr
Shares 1Y
+0.1%
Loading chart…
Median
Daily closes, split-adjusted · ratios at each fiscal year end
Company
CEOCharles Giancarlo
HQSanta Clara, CA
AuditorDeloitte & Touche LLP
Employees6,400
Year endsJanuary
Revenue by segment · FY25
Product54%
Service46%
Compounded growth & averages
10Y
5Y
3Y
TTM
Share price
25.6%
36.4%
51.6%
34.9%
Upgrade to see 10 years
Share price: yearly compound rate of the traded close; the last column is the past year.
Where the cash went · FY24–FY25
$1.2B deployed
Capex
$491M
40.5%
Acquisitions
$4M
0.4%
Buybacks
$717M
59.1%
Operating cash flow over the period: $1.6B. Total debt changed by −$98M. R&D of $1.8B is already inside operating costs.
More cash than debt at the end of FY25.
Growth engines
How much of the profit growth came from new investment, and how much from running the business better.
Upgrade to see 10 years
Financials
Last 2 years · Upgrade to see 10 years · USD millions · each year opens its 10-K · FY25 = year ended Feb 1, 2026 · change vs previous year
Last 4 quarters · USD millions · quarter-end month shown · change vs same quarter a year earlier
TTM = the last four quarters, to Aug '26. Balance-sheet rows show that latest quarter. “—” where the quarters do not add up to the annual figures. No TTM for cash: our quarterly rows do not hold short-term investments yet, and annual cash includes them.
Income
Revenue
3,168
3,663+15.6%
4,262
YoY
+15.6%
Gross profit
2,213
2,578+16.5%
2,972
Gross margin
69.8%
70.4%+0.5 pp
—
Operating income
85
115+34.7%
224
Operating margin
2.7%
3.1%+0.4 pp
—
EBITDA
200
252+26.0%
—
EBITDA margin
6.3%
6.9%+0.6 pp
—
Interest expense
8
3−56.8%
—
Interest coverage
25.57x
74.55x+48.99x
—
Net income
107
188+76.3%
253
YoY
+76.3%
Net margin
3.4%
5.1%+1.8 pp
—
EPS (diluted, $)
0.31
0.55+77.4%
0.73
YoY
+77.4%
Balance sheet
Total assets
3,964
4,674+17.9%
5,220
Cash & short-term investments
738
865+17.2%
—
Accounts receivable
681
945+38.8%
—
Inventory
43
76+77.4%
—
Net PP&E
462
587+27.1%
—
Other assets
2,041
2,201+7.9%
—
Total liabilities
2,657
3,229+21.5%
3,680
Accounts payable
112
153+36.4%
—
Total debt
100
2−97.7%
—
Other liabilities
2,445
3,073+25.7%
—
Shareholders’ equity
1,306
1,446+10.7%
1,541
Total liabilities = total assets − shareholders’ equity, so it includes minority interest where a company has one.
Cash flow statement · as filed
Cash from operations
754
880+16.8%
428
Net income
107
188+76.3%
—
Depreciation & amortization
114
137+19.5%
—
Stock-based compensation
421
482+14.3%
—
Working capital & other
111
73−33.9%
—
Cash from investing
(218)
(108)n/m
—
Capex
(227)
(264)n/m
—
Acquisitions
0
(4)n/m
—
Investments bought
(472)
(459)n/m
—
Investments sold / matured
412
208−49.5%
—
Other investing
68
412+503.9%
—
Cash from financing
(510)
(645)n/m
—
Debt raised
0
0n/m
—
Debt repaid
(8)
(104)n/m
—
Buybacks
(374)
(343)n/m
—
Shares issued
27
18−32.4%
—
Other financing
(155)
(217)n/m
—
Net change in cash
26
127+396.6%
—
Free cash flow (OCF − capex)
527
616+16.9%
128
Where the cash went
Operating cash flow
754
880+16.8%
428
Reinvested in the business
227
269+18.5%
—
% of operating cash flow
30.1%
30.5%
Capex
227
264+16.6%
300
Acquisitions
0
4n/m
—
R&D (memo, already in costs)
804
963+19.8%
—
Free cash flow
527
616+16.9%
128
YoY
+16.9%
Returned to shareholders
374
343−8.4%
—
% of free cash flow
71.0%
55.6%
Buybacks
374
343−8.4%
—
Change in total debt
—
(98)
—
Cash left over
—
171
—
FCF conversion (FCF ÷ net income)
493.6%
327.2%−166.4 pp
—
Owner earnings
—
(196)
—
Owner earnings margin
—
−5.3%
—
Returns & ratios
ROIC (all capital)
9.2%
15.4%+6.2 pp
—
ROIC (operating)
5.7%
7.6%+1.9 pp
—
Net debt / EBITDA
−3.19x
−3.43x−0.24x
—
Debt / equity
0.08x
0.00x−0.07x
—
Cash conversion cycle (days)
52
68+16 d
—
ROE
8.2%
13.0%+4.8 pp
—
ROA
2.7%
4.0%+1.3 pp
—
ROCE
3.6%
4.2%+0.6 pp
—
NOPAT
62
96+56.5%
—
Invested capital (operating)
1,073
1,454+35.6%
—
Invested capital (all)
669
583−12.8%
—
Reinvestment rate
—
396.0%
—
Debtor days
78
94+16 d
—
Inventory days
16
26+9 d
—
Days payable
43
52+9 d
—
Income
Nov '25
Feb '26
May '26
Aug '26
Revenue
964
1,059
1,053
1,186
vs year-ago quarter
Gross profit
697
740
723
811
Gross margin
72.3%
69.9%
68.7%
68.4%
Operating income
54
87
20
63
Net income
55
100
24
74
vs year-ago quarter
Net margin
5.7%
9.5%
2.3%
6.3%
EPS (diluted, $)
0.16
0.29
0.07
0.21
vs year-ago quarter
Balance sheet
Nov '25
Feb '26
May '26
Aug '26
Total assets
4,218
4,674
4,750
5,220
Cash & equivalents
874
865
849
396
Total debt
2
2
—
—
Shareholders’ equity
1,403
1,446
1,442
1,541
Cash flow
Nov '25
Feb '26
May '26
Aug '26
Operating cash flow
116
268
180
(136)
Capex
63
67
68
101
Free cash flow
53
201
112
(238)
vs year-ago quarter